SCHEMBL7028891

SCHEMBL7028891

Cc1cc(C(=O)NC2CCc3cccc(N4CCN(C)CC4)c3C2)ccc1N1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 6/20 0.45
▸ SCN9A Q15858 6/20 0.45
▸ SCN5A Q14524 5/20 0.45
▸ USP30 Q70CQ3 1/20 0.44
▸ MTNR1A P48039 1/20 0.44
▸ MTNR1B P49286 1/20 0.44
▸ CYP2C19 P33261 1/20 0.43
▸ PIK3CD O00329 1/20 0.42
▸ AKT1 P31749 1/20 0.42
▸ PIK3CA P42336 1/20 0.42
▸ PIK3CB P42338 1/20 0.42
▸ PIK3CG P48736 1/20 0.42
▸ POLB P06746 2/20 0.41
▸ CNR1 P21554 1/20 0.41
▸ CNR2 P34972 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7026361 1.00 KCNH2 (0.45) KCNH2SCN9ASCN5AUSP30MTNR1A
SCHEMBL3830330 0.89 DRD2 (0.50) KCNH2SCN9ASCN5AUSP30MTNR1A
SCHEMBL7024053 0.89 DRD2 (0.50) KCNH2SCN9ASCN5AUSP30MTNR1A
SCHEMBL6820453 0.89 DRD2 (0.50) KCNH2SCN9ASCN5AUSP30MTNR1A
SCHEMBL7024691 0.85 KCNH2 (0.48) KCNH2SCN9ASCN5AMTNR1AMTNR1B
SCHEMBL7023935 0.85 KCNH2 (0.48) KCNH2SCN9ASCN5AMTNR1AMTNR1B
SCHEMBL4863525 0.84 KCNH2 (0.47) KCNH2SCN9ASCN5AUSP30MTNR1A
SCHEMBL4863518 0.84 KCNH2 (0.47) KCNH2SCN9ASCN5AUSP30MTNR1A
SCHEMBL7026526 0.83 KDM4E (0.57) KCNH2SCN9ASCN5AMTNR1AMTNR1B
SCHEMBL7026344 0.82 MTNR1A (0.52) KCNH2SCN9ASCN5AMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888319-B1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES ASTRAZENECA AB (SE) 2003-01-29 — — EP claimed
US-6124283-A Substituted 1,2,3,4-tetrahydronaphthalene derivatives ASTRA AKTIEBOLAG (SE) 2000-09-26 — — US claimed
EP-0888319-A1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES Astra Aktiebolag (SE) 1999-01-07 — — EP claimed
WO-1997034883-A1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES ASTRA AKTIEBOLAG (SE) 1997-09-25 — — WO claimed
EP-0888319-B1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES ASTRAZENECA AB (SE) 2003-01-29 — — EP disclosed
US-6410530-B1 CENTRAL NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ASTRAZENECA AB (SE) 2002-06-25 — — US disclosed
US-6124283-A Substituted 1,2,3,4-tetrahydronaphthalene derivatives ASTRA AKTIEBOLAG (SE) 2000-09-26 — — US disclosed
EP-0888319-A1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES Astra Aktiebolag (SE) 1999-01-07 — — EP disclosed
WO-1997034883-A1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES ASTRA AKTIEBOLAG (SE) 1997-09-25 — — WO disclosed
Send feedback